Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Artery Infusion Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07584018
What this trial is testing

The DoHAICs Study Expansion Phase

Who this might be right for
HCC - Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT07646717
What this trial is testing

Efficacy and Safety of HAIC Combined With Lenvatinib and PD-1 Inhibitors for Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04994236
What this trial is testing

Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy

Who this might be right for
Hepatocellular Carcinoma
Hui-Chuan Sun 49
Testing effectiveness (Phase 2)UnknownNCT05839197
What this trial is testing

A Single-arm Clinical Study of HAIC Combined With Apatinib and Camrelizumab in the Treatment of Unresectable MTM HCC

Who this might be right for
Macrotrabecular Massive Hepatocellular Carcinoma
Wan-Guang Zhang 38
Testing effectiveness (Phase 2)UnknownNCT05166772
What this trial is testing

Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）in the First-line Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00200200
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer

Who this might be right for
Hepatic MetastasesColon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 73
Testing effectiveness (Phase 2)Study completedNCT03493061
What this trial is testing

Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM

Who this might be right for
Colo-rectal CancerLiver Metastases
Sun Yat-sen University 60
Large-scale testing (Phase 3)Ended earlyNCT00110123
What this trial is testing

Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma

Who this might be right for
Intraocular MelanomaMetastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 171
Testing effectiveness (Phase 2)UnknownNCT05753163
What this trial is testing

Hepatic Arterial Infusion Chemotherapy Combined With Sintilimab and Regorafenib as Adjuvant Therapy for Colorectal Liver Metastasis Patients With a High Risk of Recurrent: a Single-arm, Phase II Study

Who this might be right for
Colorectal Liver Metastasis
Fudan University 44
Large-scale testing (Phase 3)Looking for participantsNCT05863195
What this trial is testing

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverStage IV Colorectal Cancer AJCC v8+1 more
ECOG-ACRIN Cancer Research Group 408
Large-scale testing (Phase 3)UnknownNCT03775395
What this trial is testing

HAIC Plus Lenvatinib vs HAIC Plus Sorafenib for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 250
Testing effectiveness (Phase 2)UnknownNCT06293287
What this trial is testing

Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy

Who this might be right for
Radial Artery Occlusion
Zhongshan Hospital (Xiamen), Fudan University 156
Testing effectiveness (Phase 2)Looking for participantsNCT07776080
What this trial is testing

Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Who this might be right for
HCC - Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 35
Not applicableUnknownNCT05573282
What this trial is testing

Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 50
Large-scale testing (Phase 3)Looking for participantsNCT06041477
What this trial is testing

Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC

Who this might be right for
Hepatocellular CarcinomaChemotherapy EffectChemotherapeutic Toxicity
Sun Yat-sen University 540
Testing effectiveness (Phase 2)UnknownNCT00356161
What this trial is testing

HAI Via Interventionally Implanted Port Catheter Systems

Who this might be right for
Colorectal CancerLiver NeoplasmsHepatocellular Carcinoma+2 more
Charite University, Berlin, Germany 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06389500
What this trial is testing

HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Harbin Medical University 30
Not applicableLooking for participantsNCT06333561
What this trial is testing

HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLenvatinibPD-1 Inhibitor+1 more
Sun Yat-sen University 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT00492999
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 64
Not applicableStudy completedNCT06199232
What this trial is testing

Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed From Standard Systemic Treatment

Who this might be right for
Liver Metastasis Colon CancerctDNA GenotypeMSS+1 more
Peking University 47
Next Page